Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
JCO Precision Oncology
|
December 18, 2024
Phase II Study of Defactinib (VS6063) in Patients With Tumors With <i>NF2</i> Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U
Marjorie G Zauderer, Opeyemi Jegede, David M Jackman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
Patrick Y Wen, Martin van den Bent, Gilbert Youssef, et al.
Nature Genetics
|
April 8, 2003
C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression
Jérôme Reboul, Philippe Vaglio, Jean-François Rual, et al.
Neuro-Oncology Advances
|
February 6, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes
Tyler A Lanman, Gilbert Youssef, Raymond Huang, et al.
Nature Communications
|
December 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort
J Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef, et al.
Scientific Data
|
January 27, 2026
The 2024 Brain Tumor Segmentation Challenge Meningioma Radiotherapy (BraTS-MEN-RT) dataset
Dominic LaBella, Katherine Schumacher, Michael Mix, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
JCO Precision Oncology
|
December 18, 2024
Phase II Study of Defactinib (VS6063) in Patients With Tumors With <i>NF2</i> Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U
Marjorie G Zauderer, Opeyemi Jegede, David M Jackman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2023
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults
Patrick Y Wen, Martin van den Bent, Gilbert Youssef, et al.
Nature Genetics
|
April 8, 2003
C. elegans ORFeome version 1.1: experimental verification of the genome annotation and resource for proteome-scale protein expression
Jérôme Reboul, Philippe Vaglio, Jean-François Rual, et al.
Neuro-Oncology Advances
|
February 6, 2025
Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes
Tyler A Lanman, Gilbert Youssef, Raymond Huang, et al.
Nature Communications
|
December 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohort
J Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef, et al.
Scientific Data
|
January 27, 2026
The 2024 Brain Tumor Segmentation Challenge Meningioma Radiotherapy (BraTS-MEN-RT) dataset
Dominic LaBella, Katherine Schumacher, Michael Mix, et al.
Page
of 5